1h Free Analyst Time
Global Arrhythmia Monitoring Devices Market 2021-2025Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the arrhythmia monitoring devices market and it is poised to grow by $ 2.79 bn during 2021-2025, progressing at a CAGR of 8% during the forecast period. The report on the arrhythmia monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing number of cardiac conditions due to irregularity in heart rhythms and other chronic diseases and product and geographic expansion through strategic alliances. In addition, a growing number of cardiac conditions due to irregularity in heart rhythms and other chronic diseases is anticipated to boost the growth of the market as well.
The arrhythmia monitoring devices market analysis includes product segments and geographical landscapes.
The arrhythmia monitoring devices market is segmented as below:
- By Product
- ECG and Holter monitors
- Implantable cardiac monitors
- Cardiac event monitors
- By Geography
- North America
- Europe
- ROW
- Asia
This study identifies the product launches as one of the prime reasons driving the arrhythmia monitoring devices market growth during the next few years.
The report on the arrhythmia monitoring devices market covers the following areas:
- Arrhythmia monitoring devices market sizing
- Arrhythmia monitoring devices market forecast
- Arrhythmia monitoring devices market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading arrhythmia monitoring devices market vendors that include Abbott Laboratories, AliveCor Inc., BioTelemetry Inc., BIOTRONIK SE & Co. KG, B-Secur Ltd., CardioComm Solutions Inc., General Electric Co., Hillrom, Koninklijke Philips NV, and Medtronic Plc. Also, the arrhythmia monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global arrhythmia monitoring devices market: Abbott Laboratories, AliveCor Inc., BioTelemetry Inc., BIOTRONIK SE & Co. KG, B-Secur Ltd., CardioComm Solutions Inc., General Electric Co., Hillrom, Koninklijke Philips NV, and Medtronic Plc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is product launches.'
According to the report, one of the major drivers for this market is the growing number of cardiac conditions due to irregularity in heart rhythms and other chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- AliveCor Inc.
- BioTelemetry Inc.
- BIOTRONIK SE & Co. KG
- B-Secur Ltd.
- CardioComm Solutions Inc.
- General Electric Co.
- Hillrom
- Koninklijke Philips NV
- Medtronic Plc